Examples of 'antiangiogenic' in a sentence
Meaning of "antiangiogenic"
antiangiogenic (adjective) - referring to substances or treatments that inhibit the growth of new blood vessels
Show more definitions
- That inhibits angiogenesis (especially when used to combat cancer).
- Any drug of this kind.
How to use "antiangiogenic" in a sentence
Basic
Advanced
antiangiogenic
Impact of antiangiogenic therapy to prevent vision loss.
The chemotherapeutic agent may be an antiangiogenic agent.
Optimizing antiangiogenic therapy as a potentially universal chemosensitizing strategy.
The compounds are further useful as antiangiogenic agents.
Also antiangiogenic activity has been reported.
Examples of such substance include antiangiogenic agents.
Other antiangiogenic compounds are disclosed herein.
The desulphated heparins have antiangiogenic activity.
The antiangiogenic agent is delivered from a polymeric carrier.
Thalidomide is one such antiangiogenic agent.
Antiangiogenic treatment improves survival in animal model of ovarian cancer.
Thrombospondins are a family of secreted glycoproteins with antiangiogenic functions.
They have shown excellent antiangiogenic results in the laboratory.
Current or previous treatment with an antiresorptive or antiangiogenic agent.
Antiangiogenic drugs oppose the formation of this network of vessels.
See also
The next generation of antiangiogenic drugs.
Use of such antiangiogenic agents is also contemplated by the present invention.
Investigations into the effects of antiangiogenic drugs are ongoing.
Ramucirumab is an antiangiogenic therapy and may increase the risk of gastrointestinal perforations.
Retinoids are tested as potential antiangiogenic agents.
Currently trials employing antiangiogenic strategies against angiosarcoma are ongoing.
These enzymes are biological targets for antiangiogenic activity.
Ramucirumab is an antiangiogenic therapy and may increase the risk of severe bleeding.
The compounds of this invention have antiangiogenic properties.
A number of antiangiogenic compounds have been developed in the past to reach this goal.
This agent has also been noted to be a potent antiangiogenic.
So we created an antiangiogenic paste.
The neovasculature in endothelial cells is a therapeutic target for an antiangiogenic agent.
These derivatives are provided with antiangiogenic activity and are devoid of anticoagulant activity.
Treatment by subconjunctival injections and topical applications of antiangiogenic oligonucleotide.
And here is a growing list of antiangiogenic foods and beverages that we are interested in studying.
Current treatment of advanced metastatic cancer benefits from antiangiogenic drugs.
Squalamine has potent antiangiogenic activity and is a preferred compound for cancer therapy.
The compounds according to the invention described herein possess antiangiogenic activity.
The antiangiogenic and antiproliferative activities of the compounds of the invention are demonstrated below.
These oligonucleotides have remarkable antiangiogenic and antitumor activities.
This strong antiangiogenic effect could already be observed macroscopically and confirmed histologically.
Toxicity management of antiangiogenic agents.
Its antiangiogenic effects help slow down or even prevent the growth of new blood vessels.
Combination with an antiangiogenic agent.
The oligonucleotides according to the invention and the compositions containing them are thus antiangiogenic agents.
Compounds of natural origin with an antiangiogenic activity useful in human therapy are already known.
These are crucial parameters for evaluating accurately any retinal antiangiogenic effect.
Other studies relate the antiangiogenic use of endostatin for treating ocular neovascularization.
The model was then used for testing the efficacy of the antiangiogenic agents.
Tea catechins are also found to have antiangiogenic properties that may prevent obesity.
Antiangiogenic activity on HUVEC was assessed using a tube formation assay.
Retinoids useful for treating cancer or having antiangiogenic activity are already known.
Most antiangiogenic therapies currently being evaluated target the VEGF pathway.
Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer.
